AINewsBreaks Archive - Page 16 of 47

ThursdayAug 21, 2025 11:55 am

AINewsBreaks – Onar Holding Corporation (OTCQB: ONAR) Reports Q2 2025 Results, Advances AI Strategy and Acquisition Pipeline

Onar (OTCQB: ONAR), an AI-powered marketing agency network, announced financial results for the second quarter ended June 30, 2025, highlighting 28% year-to-date revenue growth compared to the prior year. The Company reported a Q2 net loss, primarily from compliance and non-operating expenses, while converting $142,000 of debt into equity and repaying nearly $300,000 in principal. ONAR began closing its Series E financing round and appointed Scott Kauffman as Chairman along with new independent directors Mark Gazit and Reda Raad. Strategic initiatives included partnering with IQSTEL’s Reality Border to co-develop a multi-agent AI platform for Cortex, signing a definitive agreement to…

WednesdayAug 20, 2025 3:20 pm

AINewsBreaks – ONAR Holding Corp. (ONAR) at the Forefront of ‘Fundamental Transformation’ in AI-Driven SEO

ONAR Holdings (OTCQB: ONAR) was featured in a recent Forbes article that highlights a new era of AI-driven search and advertising. In the interview, the company’s CEO Claude Zdanow explained how ONAR is leveraging its AI-powered technologies to help mid-market brands thrive in the age of conversational AI search. Speaking of the seismic pivot from traditional Google search toward AI-enhanced platforms, he explained, “We’re shifting from gaming Google’s algorithm to engaging in real-time AI searches that respond directly to what we ask. That’s the fundamental transformation unfolding right now… Language model optimization is about creating content that’s actually relevant and…

WednesdayAug 20, 2025 10:30 am

AINewsBreaks – Wearable Devices Ltd. (NASDAQ: WLDS, WLDSW) Partners With Media Exceed to Bring Neural Wearables to Japan

Wearable Devices (NASDAQ: WLDS, WLDSW), a technology company developing AI-powered touchless sensing wearables, said it formed a collaboration with Japan-based Media Exceed Co. Ltd., which will act as a non-exclusive reseller of the company’s Mudra Band and Mudra Link. The agreement aims to expand availability of Wearable Devices’ neural interface products in Japan through Media Exceed’s e-commerce platform, using both drop shipping and wholesale models for streamlined order fulfillment and local customer support. To view the full press release, visit https://ibn.fm/LDWVf About Wearable Devices Ltd. Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) is a growth company pioneering human-computer interaction through its…

WednesdayAug 20, 2025 9:33 am

AINewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Secures $20 Million Private Placement With Ondas Holdings (NASDAQ: ONDS) and Unusual Machines (NYSE: UMAC)

Safe Pro Group (NASDAQ: SPAI), a provider of AI-powered defense and security solutions, said it entered into definitive agreements for a private placement with strategic investors including Ondas Holdings Inc. (NASDAQ: ONDS) and Unusual Machines Inc. (NYSE: UMAC). The deal covers 2 million shares at $4 each and warrants for 2 million shares at $6 each, representing up to $20 million. The investment is expected to accelerate commercialization of Safe Pro’s patented AI technologies, including its Object Threat Detection system and Navigation Observation Detection Engine, which detect landmines, map terrain and analyze drone imagery in real time. The company said…

TuesdayAug 19, 2025 12:29 pm

AINewsBreaks – Helping SMEs Think Big: BluSky AI Inc. (BSAI) Bridges Infrastructure Gap

BluSky (OTC: BSAI) is focused on enabling small and mid-sized businesses to join the AI revolution. The company was featured in a recent article that discusses this, stating, “According to Forbes, three out of five SMBs plan to deploy AI within two years, but many lack access to the infrastructure required to do so. BluSky’s modular approach helps solve that. Whether it’s a startup training for its first large model or a university researching new applications, SkyMod units offer right-sized solutions that can grow with demand, and without the overhead of building and managing a traditional data center… BluSky AI’s modular…

FridayAug 15, 2025 11:09 am

AINewsBreaks – Glidelogic Corp. (USOTC: GDLG) Launches Advanced AI-Powered ResearchMind Globally

Glidelogic (USOTC: GDLG) today announced the worldwide rollout of its upgraded ResearchMind platform after four months of invitation-only beta testing. Now available for $24.99 per full analysis report, the release integrates OpenAI GPT-5 and Anthropic Claude Opus 4.1 in its Pro version for academic partners, offering enhanced natural-language comprehension, domain adaptation and reasoning depth. Key improvements include extended reasoning time for deeper multi-stage analysis and expanded iteration cycles for more accurate, publication-ready proposals. “Our vision has always been to make AI an active collaborator in hypothesis formation—not just a productivity tool,” said CEO Fred (Yitian) Xue. “Leveraging compute as equity…

FridayAug 15, 2025 10:34 am

AINewsBreaks – WEBUY GLOBAL LTD (NASDAQ: WBUY) Closes $3 Million Offering of Shares and Pre-Funded Warrants

WEBUY GLOBAL (NASDAQ: WBUY), a technology-driven company transforming community e-commerce and travel across Southeast Asia, has closed its offering of 721,918 Class A ordinary shares and pre-funded warrants to purchase up to 100,000 Class A ordinary shares to certain institutional investors. The transaction generated approximately $3 million in gross proceeds before placement agent fees and other expenses. D. Boral Capital LLC served as exclusive placement agent, with Ortoli Rosenstadt LLP advising the company and Hunter Taubman Fischer & Li LLC representing the placement agent. To view the full press release, visit https://ibn.fm/9e6LL About WEBUY GLOBAL LTD WEBUY GLOBAL LTD. is…

ThursdayAug 14, 2025 10:11 am

AINewsBreaks – Lantern Pharma (NASDAQ: LTRN) Reports Q2 2025 Results, Achieves Complete Responses in Multiple Trials, Expands AI Platform

Lantern Pharma (NASDAQ: LTRN), a clinical-stage biopharma company leveraging its RADR(R) AI/ML platform for oncology drug discovery and development, announced Q2 2025 results and portfolio updates. The company reported complete responses in patients across two trials — LP-300 in advanced NSCLC and LP-284 in refractory diffuse large B-cell lymphoma — along with completion of LP-184 Phase 1a enrollment, positioning it for Phase 1b/2 studies in high-value indications. LP-184 has FDA Fast Track and multiple Rare Pediatric Disease designations and showed significant survival gains in ATRT models. Lantern strengthened its IP with a European patent allowance for LP-284 and publication of…

TuesdayAug 12, 2025 1:35 pm

AINewsBreaks – Onar Holding Corporation (OTCQB: ONAR) Details Board Additions, AI Partnerships and M&A Moves

Onar (OTCQB: ONAR), a marketing technology company and global network of performance-driven agencies, issued a corporate update highlighting new board appointments and strategic growth initiatives. Scott Kauffman, former chairman and CEO of MDC Partners, has been named chairman of the board, joined by Mark Gazit, co-founder and former CEO of ThetaRay; Reda Raad, group CEO and co-founder of TBWA\RAAD; Jon Bond, co-founder of Kirshenbaum & Bond and former CEO of Big Fuel; and Howard D. Palefsky, chair of the governance and nominating committee. ONAR expanded its AI infrastructure through a strategic partnership with IQSTEL (NASDAQ: IQST) to develop a multi-agentic…

TuesdayAug 12, 2025 11:11 am

AINewsBreaks – Fifty 1 Labs, Inc. (OTC: FITY) and BioSpark AI Achieve Major Milestone in AI-Driven Drug Repurposing

Fifty 1 Labs (OTC: FITY), through its subsidiary Fifty1 AI Labs and in partnership with BioSpark AI Technologies Inc., has transformed more than 10,000 unstructured case reports into a structured, queryable database of over 2,000 real-world patient treatment-outcome pathways. Built using BioSpark’s patented natural language processing system and Fifty1’s proprietary AI modeling, the dataset provides a high-fidelity foundation for therapeutic discovery in complex conditions such as chronic fatigue, neuroinflammation and post-viral syndromes. The collaboration, which aligns with Fifty1 Labs’ intent to acquire BioSpark, has prioritized off-patent drug candidates with market opportunities ranging from $1 billion to over $160 billion. The…

AINewsWire provides insights in the emerging sector of Artificial Intelligence.

Contact us: (512) 354-7000

AINewsBreaks